Sinovac Biotech Ltd
SVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001084201
No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Sinovac Biotech Ltd changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 9 | 4 | −5 |
| Shares | 9.02M | 8.95M | −69.2K (−0.8%) |
| Value | $380.2M | $957.4M | +$577.2M (+151.8%) |
New holders (0)
Institutions that held Sinovac Biotech Ltd at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (5)
Institutions that held Sinovac Biotech Ltd at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| IFP Advisors, Inc | 18 | $8.00K |
| California Public Employees Retirement System | 68,732 | $0 |
| Assetmark, Inc | 14 | $0 |
| Transamerica Financial Advisors, Inc. | 2 | $0 |
| Tower Research Capital LLC (TRC) | 424 | $0 |